Skip to content

Patency of luminal heparinised polytetrafluoroethylene (PTFE) grafts compared with unheparinised PTFE grafts

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN77471962
Enrollment
484
Registered
2005-10-05
Start date
2005-07-01
Completion date
Unknown
Last updated
2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lower limb ischaemia Circulatory System Atherosclerosis

Interventions

Use of endoluminal heparinised PTFE graft instead of unheparinised PTFE grafts. Please note that recruitment for this trial completed on 31/12/2008 and the trial is in follow-up as of 20/08/2009. P

Sponsors

W. L. Gore and Associates (Sweden)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with chronic lower limb ischeamia, who require a femoropopliteal or femorofemoral bypass with the use of an artificial graft

Exclusion criteria

Exclusion criteria: Acute lower limb ischaemia, expected poor surveillance postoperatively, heparin allergy

Design outcomes

Primary

MeasureTime frame
Patency

Secondary

MeasureTime frame
1. Secondary interventions 2. Cost effectiveness 3. Amputations

Countries

Denmark

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026